Rights and permissions
About this article
Cite this article
Avastin vs Lucenits: NICE backs unlicensed Avastin for blindness. Pharmacoecon. Outcomes News 620, 10 (2011). https://doi.org/10.2165/00151234-201106200-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106200-00029